Corporate

Zydus Lifesciences Limited

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 21, 2026, titled “Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India”. |SUBJECT: Press Release

Related Posts

PDS Limited

PDS Limited has informed the Exchange about Frauds/Default by employees |SUBJECT: Frauds/Default by employees

CEAT Limited

Confirmation of Redemption/Payment of Interest and Principal |SUBJECT: Confirmation of Redemption/Payment of Interest and Principal

Leave a Reply

Your email address will not be published. Required fields are marked *